27 September 2016

UCLPartners Chairman, Ajay Kakkar, announces new leadership arrangements for UCLPartners

The Board of UCLPartners is pleased to confirm that Dr Charlie Davie, who is Managing Director of UCLPartners Academic Health Science Network, will assume the responsibilities of Managing Director of the partnership, working closely with Professor David Lomas, Academic Director of UCLPartners; and Professor Mike Roberts, Clinical Academic Lead for Population Health and Place-Based Care at UCLPartners.

The Board continues to review the challenges facing the partnership and these arrangements will remain in place until the end of the financial year to ensure continuity of the leadership at UCLPartners.

Professor Andrew Morris, currently Independent Chair of the UCLPartners Informatics Programme, will join the full UCLPartners Board in the near future to further support UCLPartners’ integrated academic agenda.

Together this clinical academic leadership team will work with local and national partners to ensure UCLPartners continues to meet its goal of transforming the health and wellbeing of the population.

Dr Davie has an extensive track record in partnership working for the benefit of patients and the population, and was in the original UCLPartners team when it was established in 2009.  He played a pivotal role in redesigning stroke services across London in 2010, which resulted in significantly improved outcomes for patients.  In 2014, Dr Davie was appointed as Managing Director of UCLPartners Academic Health Science Network, taking the partnership from strength-to-strength and providing strategic direction for high profile initiatives including NHS Test Beds, the NHS Innovation Accelerator, DigitalHealth.London and the soon to be published Accelerated Access Review.

Dr Davie takes on the responsibilities from Professor Sir David Fish who is standing down as UCLPartners Managing Director today after 41 years in healthcare and science.

Chair of UCLPartners, Ajay Kakkar, said: “On behalf of the Board, I would like to recognise the lasting legacy of David Fish’s remarkable contribution in having taken forward partnership working for the benefit of patients and populations with such determination and commitment.  We are indebted to him.

Looking forward, the Board is delighted that Charlie Davie has agreed to take on these additional responsibilities, working with a team of senior academics to drive improvements in discovery science, innovation into practice and population health.”

Dr Davie said: “I am very excited at the prospect of working with many inspirational colleagues from the partnership and within the organisation to take UCLPartners into its next phase. I look forward to working closely with our partners to ensure we are supporting them in the best way possible. 

“I have been so lucky to have first worked with David 26 years ago and subsequently in multiple roles. On a personal level, I will always be hugely grateful to him for his kindness, mentorship, support and wisdom throughout this time. He is quite simply an exceptional individual who has never stopped role modelling the most important value of UCLPartners; always doing the right thing for the patients and population through supporting partnership working. I’m sure many people will agree that we owe David an immense debt of gratitude for all he has done.”